Physician profile

Michael E Kasper

Cardiovascular Disease · Saddle River, NJ

NPI 1124280250

$1,436.43

in general payments reported to CMS, 2019-2025

7 companies · $300 in 2025

The $300 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$986.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $578.75 2023-2025 Watchman Flx, Watchman Access System, Watchman
Medtronic Vascular, INC. $313.81 2020
Acadia Pharmaceuticals INC $226.88 2023 Nuplazid
Bioprotect Medical, INC. $134.01 2025 Bioprotect Balloon Implant System
Boehringer Ingelheim Pharmaceuticals, INC. $123.48 2019
Heartflow, INC. $36.13 2022-2025
Gilead Sciences, INC. $23.37 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael E Kasper

$1,436.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $300 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/142227/michael-e-kasper

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.